[引用][C] Revoking the Privilege: Targeting HER2 in the CNS (Relates to article by Emanuel, et al., Fast Forward 1 Nov 07)
JN Contessa, DA Hamstra - Molecular Pharmacology, 2007 - ASPET
Pharmacologic agents developed for cancer therapy have traditionally relied on a
therapeutic ratio of effects between tumors and normal tissue. Over the past decade this …
therapeutic ratio of effects between tumors and normal tissue. Over the past decade this …